Ginzberg Sara P, Soegaard Ballester Jacqueline M, Wirtalla Christopher J, Morales Knashawn H, Pryma Daniel A, Mandel Susan J, Kelz Rachel R, Wachtel Heather
Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA.
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ann Surg Oncol. 2023 May;30(5):2928-2937. doi: 10.1245/s10434-023-13158-3. Epub 2023 Feb 7.
The 2015 American Thyroid Association (ATA) guidelines reduced the recommended extent of therapy for low-risk thyroid cancers. Little is known about the impact of these changes on overall treatment patterns and on previously described racial/ethnic disparities in guideline-concordant care. This study aimed to assess trends in thyroid cancer care before and after release of the 2015 guidelines, with particular attention to racial/ethnic disparities.
Patients with well-differentiated thyroid cancer were identified from the National Cancer Database (2010-2018). An interrupted time series design was used to assess trends in treatment before and after the 2015 guidelines. Appropriateness of surgical and radioactive iodine (RAI) treatment was determined based on the ATA guidelines, and the likelihood of receiving guideline-concordant treatment was compared between racial/ethnic groups.
The study identified 309,367 patients (White 74%, Black 8%, Hispanic 9%, Asian 6%). Between 2010 and 2015, the adjusted probability of appropriate surgery was lower for Black (- 2.1%; p < 0.001), Hispanic (- 1.0%; p < 0.001), and Asian (- 2.1%; p < 0.001) patients than for White patients. After 2015, only Hispanic patients had a lower probability of undergoing appropriate surgical therapy (- 2.6%; p = 0.040). Similarly, between 2010 and 2015, the adjusted probability of receiving appropriate RAI therapy was lower for the Hispanic (- 3.6%; p < 0.001) and Asian (- 2.4%; p < 0.001) patients than for White patients. After 2015, the probability of appropriate RAI therapy did not differ between groups.
Between 2010 and 2015, patients from racial/ethnic minority backgrounds were less likely than White patients to receive appropriate surgical and RAI therapy for thyroid cancer. After the 2015 guidelines, racial/ethnic disparities in treatment improved.
2015年美国甲状腺协会(ATA)指南降低了低风险甲状腺癌的推荐治疗范围。对于这些变化对总体治疗模式以及先前描述的指南一致性治疗中的种族/民族差异的影响,人们知之甚少。本研究旨在评估2015年指南发布前后甲状腺癌治疗的趋势,尤其关注种族/民族差异。
从国家癌症数据库(2010 - 2018年)中识别出分化型甲状腺癌患者。采用中断时间序列设计来评估2015年指南发布前后的治疗趋势。根据ATA指南确定手术和放射性碘(RAI)治疗的适宜性,并比较不同种族/民族群体接受指南一致性治疗的可能性。
该研究共纳入309,367例患者(白人占74%,黑人占8%,西班牙裔占9%,亚裔占6%)。2010年至2015年期间,黑人(-2.1%;p < 0.001)、西班牙裔(-1.0%;p < 0.001)和亚裔(-2.1%;p < 0.001)患者接受适当手术的调整概率低于白人患者。2015年后,只有西班牙裔患者接受适当手术治疗的概率较低(-2.6%;p = 0.040)。同样,2010年至2015年期间,西班牙裔(-3.6%;p < 0.001)和亚裔(-2.4%;p < 0.001)患者接受适当RAI治疗的调整概率低于白人患者。2015年后,各群体之间接受适当RAI治疗的概率没有差异。
2010年至2015年期间,来自种族/民族少数群体背景的患者接受甲状腺癌适当手术和RAI治疗的可能性低于白人患者。2015年指南发布后,治疗中的种族/民族差异有所改善。